Hall Laurie J Trustee Esperion Therapeutics, Inc. Transaction History

Hall Laurie J Trustee

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	SELL	$5.45 - $8.13 $354 - $528	-65 Reduced 32.5%	135 $1,000
Q3 2021 Oct 04, 2021	SELL	$11.34 - $21.37 $1,360 - $2,564	-120 Reduced 37.5%	200 $2,000
Q4 2020 Jan 25, 2021	BUY	$24.2 - $35.76 $2,420 - $3,576	100 Added 45.45%	320 $8,000
Q3 2020 Oct 09, 2020	BUY	$31.18 - $52.71 $1,559 - $2,635	50 Added 29.41%	220 $8,000
Q4 2019 Feb 12, 2020	BUY	$35.4 - $59.82 $2,478 - $4,187	70 Added 70.0%	170 $10,000
Q3 2019 Oct 25, 2019	BUY	$34.47 - $47.53 $1,034 - $1,425	30 Added 42.86%	100 $4,000
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $369 - $591	-10 Reduced 12.5%	70 $3,000
Q2 2018 Aug 01, 2018	SELL	$36.2 - $76.4 $3,982 - $8,404	-110 Reduced 57.89%	80 $3,000
Q4 2017 Jan 30, 2018	SELL	$43.47 - $67.43 $3,912 - $6,068	-90 Reduced 32.14%	190 $13,000
Q2 2017 Aug 22, 2017	BUY	N/A	280	280 $0

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.